Zhang, Q., Ding, Y., Shu, Y., & Chen, J. (2023). A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data. BMC.
Chicago Style (17th ed.) CitationZhang, Qilin, Yiling Ding, Yamin Shu, and Jing Chen. A Real-world Disproportionality Analysis of Rucaparib: Post-marketing Pharmacovigilance Data. BMC, 2023.
MLA (9th ed.) CitationZhang, Qilin, et al. A Real-world Disproportionality Analysis of Rucaparib: Post-marketing Pharmacovigilance Data. BMC, 2023.
Warning: These citations may not always be 100% accurate.